about
Molecular strategies to inhibit HIV-1 replicationIdentification of endogenous retroviral reading frames in the human genomeA murine leukemia virus with Cre-LoxP excisible coding sequences allowing superinfection, transgene delivery, and generation of host genomic deletionsActivation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesisAntisense transcription in gammaretroviruses as a mechanism of insertional activation of host genesDeregulated Nras expression in knock-in animals harboring a gammaretroviral long terminal repeat at the Nras/Csde1 locus.Mutational library analysis of selected amino acids in the receptor binding domain of envelope of Akv murine leukemia virus by conditionally replication competent bicistronic vectors.Change of tropism of SL3-2 murine leukemia virus, using random mutational librariesLigand presentation on a synthetic flexible hinge in Moloney murine leukemia virus SU supports entry via a heterologous receptor.Gene conversion and purifying selection of a placenta-specific ERV-V envelope gene during simian evolution.Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas.The use of combinatorial topographical libraries for the screening of enhanced osteogenic expression and mineralization.Identification of distinct topographical surface microstructures favoring either undifferentiated expansion or differentiation of murine embryonic stem cells.Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes.Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors.A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoformProximity ligation assay combined with flow cytometry is a powerful tool for the detection of cytokine receptor dimerization.Nras overexpression results in granulocytosis, T-cell expansion and early lethality in mice.Functional selection of shRNA loops from randomized retroviral librariesSafety features of retroviral vectors.Human endogenous retroviruses sustain complex and cooperative regulation of gene-containing loci and unannotated megabase-sized regions.Two Virus-Induced MicroRNAs Known Only from Teleost Fishes Are Orthologues of MicroRNAs Involved in Cell Cycle Control in HumansA tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virusImpairment of alternative splice sites defining a novel gammaretroviral exon within gag modifies the oncogenic properties of Akv murine leukemia virus.Silencing of endogenous envelope genes in human choriocarcinoma cells shows that envPb1 is involved in heterotypic cell fusions.Ethical perspectives on RNA interference therapeutics.Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response elementLoss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.Activation of the brain-specific neurogranin gene in murine T-cell lymphomas by proviral insertional mutagenesis.Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation.Utility of next-generation RNA-sequencing in identifying chimeric transcription involving human endogenous retroviruses.Immune suppressive activity of the influenza fusion peptide.Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells.Epigenetic marking and repression of porcine endogenous retroviruses.Coupling of receptor interference and a host-dependent post-binding entry deficiency in a gammaretroviral envelope proteinEnhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.Co-localization of gammaretroviral RNAs at their transcription site favours co-packaging.Antiviral activity of small interfering RNAs: specificity testing using heterologous virus reveals interferon-related effects overlooked by conventional mismatch controls.
P50
Q24799813-D02C3867-3C01-4564-9559-1F4AE992064AQ24804743-F18A826D-D1EB-4CEB-B1EE-2541FCBFF630Q24804914-2D849BD5-7FC3-49D5-97D5-A54B85750ACFQ28247627-9F41B1D5-3CEB-4674-8427-D23142A2487AQ28272333-A292CC48-BB1D-4B66-91EB-E017215BFF30Q31111203-C575040B-9B26-4B34-8B92-5C574B0E3D91Q33193900-466E1D1B-B59E-4F1C-9264-E1F767C940B3Q33205912-60D63B30-662A-4C62-B977-68893EF185A9Q33276316-FD85364A-934C-4974-A7B8-B74A020E64EAQ33372941-50C006F6-D463-4FFF-B078-9CA58848B495Q33401677-F5CCC304-BB4A-440F-9ECE-5157824E9507Q33403946-AA343576-2844-41B2-82F2-77AD8771800EQ33464555-94ECE1F0-8163-47D8-BB58-A3A75FE68001Q33756543-ADE3CB1A-BB0A-4EBD-9DEA-F61C87131B73Q33903154-EC8ACADA-4CA1-4FEB-BE4E-E3D2E2C625ADQ33905329-A5FBE16F-64D9-4AE2-BECF-090DED5C8A08Q34037033-697DED30-2BD8-47FA-B55A-F0AAA31ED8F2Q34372571-F3BDC5CE-36BB-47AB-9963-41E05DFE62E8Q34389272-A57B0174-9F52-4D56-8E50-1D8AA353F72FQ34835991-ECC5B909-99A0-44B8-A6F9-45118B1175A0Q35576351-A2356F7F-6A6C-44A0-B0F7-F4D2A2F2E5E9Q35710334-8E765A5D-AF68-48AF-8EA5-1E2FCA044480Q35847639-D68CDA84-CB82-4BBD-A868-E0A19FB6F5EDQ35919339-F240EBB0-E479-4D7E-B4D7-CE9DF3655001Q36523122-A0679B7D-4300-4EAB-B0B0-3C7670BB9349Q36743751-B6A2BAFC-997B-40E7-868D-65707ACD39F3Q37033163-0AFFA56D-FED1-4182-844C-E8F17CC1045FQ37275131-4A3FD50E-148D-453E-A90D-1FEF305B6494Q37325255-D6FD4E1B-4878-4FB7-86A5-61B96C48F405Q37596450-2166501E-F0B3-4049-ADAB-C1DF76ABF741Q37747489-2F90D3FF-F5B6-4875-AA77-558FDCA24EB1Q38344498-D9A95DBC-F819-46C0-A2A2-3D4B38AD7CDBQ38714233-AD4A4901-176A-480D-9BBF-0CD71B24209AQ38827205-4F4D58EC-1D28-4F3F-8597-29769576BB28Q38852007-698792DD-51A2-4143-A8ED-CBD29C506D1FQ39209518-33D1E073-0E88-4C6C-BEE8-71CC8434E4EFQ39228294-4AAE40C3-E137-4D51-9604-A86635F4BF90Q40178062-988BB5BA-530C-4365-AB88-CC90EB73A32BQ40254686-9FEFBA4C-47C2-455C-B48B-0DC199A0B532Q40316039-503DFF28-AD95-477E-8191-4115C75590B6
P50
name
Finn Skou Pedersen
@ast
Finn Skou Pedersen
@en
Finn Skou Pedersen
@es
Finn Skou Pedersen
@nl
type
label
Finn Skou Pedersen
@ast
Finn Skou Pedersen
@en
Finn Skou Pedersen
@es
Finn Skou Pedersen
@nl
prefLabel
Finn Skou Pedersen
@ast
Finn Skou Pedersen
@en
Finn Skou Pedersen
@es
Finn Skou Pedersen
@nl